 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Illumina CEO Discusses ENCODE, GWAS, and NIH Funding at Investor Conference
September 18, 2012
Illumina CEO Discusses ENCODE, GWAS, and NIH Funding at Investor Conference
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina to Remain Secure if NIH Budget Shrinks as Projected, CEO Predicts
September 20, 2011 / BioArray News - Q&A: NCI's Stephen Chanock on the Three Waves of Genome-Wide Association Studies
March 1, 2011 / BioArray News - At Investor Confab, Illumina CFO Discusses Sequestration, Japanese Market, BlueGnome
March 12, 2013 / BioArray News - Q&A: Chinese GWAS Expert Yongyong Shi Makes the Case for Population-Specific Arrays
December 18, 2012 / BioArray News - Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News